Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Ouzan

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Presse Medicale (Paris, France : 1983)|October 2, 2012
[Treatment of chronic hepatitis viral C: new associations]Denis Ouzan
Presse Medicale (Paris, France : 1983)|July 6, 2004
[The prognostic tools of hepatitis C virus infections]Philipe Halfon, Denis Ouzan, Laurent Cattan, et al.
Presse Medicale (Paris, France : 1983)|July 6, 2004
[A pluridisciplinary point of view of hepatitis C virus infections]Philipe Halfon, Denis Ouzan, Laurent Cattan, et al.
Presse Medicale (Paris, France : 1983)|July 6, 2004
[The diagnostic tools of hepatitis C virus infections]Philippe Halfon, Denis Ouzan, Laurent Cattan, et al.
Gastroenterologie Clinique Et Biologique|October 30, 2007
[HCV non-responder patients: definition of non-response and treatment strategy]Patrick Marcellin, Marc Bourlière, Jean-Michel Pawlotsky, et al.
Journal of Clinical Microbiology|July 11, 2006
Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infectionPhilippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
Comparative Hepatology|December 24, 2005
Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patientsDenis Ouzan, Hacène Khiri, Guillaume Pénaranda, et al.
Gastroenterologie Clinique Et Biologique|February 21, 2003
[Screening and hepatitis C management survey in general medicine in the Alpes-Maritimes and east Var area]Denis Ouzan, Philippe Hofliger, Philippe Cavailler, et al.
Scientific Reports|May 28, 2024
Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver diseaseDenis Ouzan, G Penaranda, M Jlaiel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 5, 2013
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogsDenis Ouzan, Guillaume Pénaranda, Hélène Joly, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Presse Medicale (Paris, France : 1983)|October 2, 2012
[Treatment of chronic hepatitis viral C: new associations]Denis Ouzan
Presse Medicale (Paris, France : 1983)|July 6, 2004
[The prognostic tools of hepatitis C virus infections]Philipe Halfon, Denis Ouzan, Laurent Cattan, et al.
Presse Medicale (Paris, France : 1983)|July 6, 2004
[A pluridisciplinary point of view of hepatitis C virus infections]Philipe Halfon, Denis Ouzan, Laurent Cattan, et al.
Presse Medicale (Paris, France : 1983)|July 6, 2004
[The diagnostic tools of hepatitis C virus infections]Philippe Halfon, Denis Ouzan, Laurent Cattan, et al.
Gastroenterologie Clinique Et Biologique|October 30, 2007
[HCV non-responder patients: definition of non-response and treatment strategy]Patrick Marcellin, Marc Bourlière, Jean-Michel Pawlotsky, et al.
Journal of Clinical Microbiology|July 11, 2006
Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infectionPhilippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
Comparative Hepatology|December 24, 2005
Kinetics of hepatitis C virus RNA load during pegylated interferon alpha-2a and ribavirin treatment in naïve genotype 1 patientsDenis Ouzan, Hacène Khiri, Guillaume Pénaranda, et al.
Gastroenterologie Clinique Et Biologique|February 21, 2003
[Screening and hepatitis C management survey in general medicine in the Alpes-Maritimes and east Var area]Denis Ouzan, Philippe Hofliger, Philippe Cavailler, et al.
Scientific Reports|May 28, 2024
Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver diseaseDenis Ouzan, G Penaranda, M Jlaiel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 5, 2013
Add-on peg-interferon leads to loss of HBsAg in patients with HBeAg-negative chronic hepatitis and HBV DNA fully suppressed by long-term nucleotide analogsDenis Ouzan, Guillaume Pénaranda, Hélène Joly, et al.
Pageof 7